Prognostic significance of CD147 in patients with glioblastoma.
about
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-AnalysisThe altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transportersThe roles of CD147 and/or cyclophilin A in kidney diseasesEMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival.Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression.Elevated CD147 expression is associated with shorter overall survival in non-small cell lung cancer.The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literatureCD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomasCD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-AnalysisCD147 and glioma: a meta-analysis.Expression and prognostic value of SFRP1 and β-catenin in patients with glioblastomaCD147 knockdown improves the antitumor efficacy of trastuzumab in HER2-positive breast cancer cellsThe roles of CD147 in the progression of gliomas.CPEB4 interacts with Vimentin and involves in progressive features and poor prognosis of patients with astrocytic tumors.CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis.Prognostic role of IDH mutations in gliomas: a meta-analysis of 55 observational studies.The clinicopathological significance and prognostic value of EMMPRIN overexpression in cancers: evidence from 39 cohort studies.The Clinical Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis.
P2860
Q26771312-4B6301D1-282A-4DF0-885E-D7121943CDC5Q28072360-F3039CC5-6E99-4F16-A985-3D4AC8CBF5CAQ28083416-1E7A24CE-6C65-45FA-A299-D644CFAA98DFQ33747651-DCD5368D-F3EA-40AC-91FE-E6A70B1ECF1AQ33842928-99AC710F-B9D2-4AFD-AE29-EF23196A59EAQ33914079-72038333-2AD7-431E-9D36-7D0955C87A04Q34486547-CBDC742B-AC2C-4226-9145-B21717C677B0Q36038630-66FFA596-1AEF-498C-89A9-21BA0C4C21E2Q36339219-8DBD8EC4-D84A-4A3B-B323-312F5E7A250EQ36385821-8231EEE1-9F8E-47E4-B317-F23B103CD0FDQ36502673-10314167-B88C-4A24-A749-74725EC7EDD2Q37628926-10B35D6A-382B-4DF4-B284-EE0A1AD1DD27Q38594492-37E48150-4B02-457A-88AA-DAB3605C8129Q38945218-E7DDB252-5884-4CED-B5B6-501C29C9FE93Q38949683-47EF2381-CE6F-4D97-AFB7-85D683A30BAFQ41536288-125873F8-620B-4A65-B92C-F4E140CD5CF6Q43879024-16266B78-19DC-4035-B42A-AFEA168A96CCQ52606179-D561F60B-7300-4227-96C6-2F813FC68561
P2860
Prognostic significance of CD147 in patients with glioblastoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Prognostic significance of CD147 in patients with glioblastoma.
@en
Prognostic significance of CD147 in patients with glioblastoma.
@nl
type
label
Prognostic significance of CD147 in patients with glioblastoma.
@en
Prognostic significance of CD147 in patients with glioblastoma.
@nl
prefLabel
Prognostic significance of CD147 in patients with glioblastoma.
@en
Prognostic significance of CD147 in patients with glioblastoma.
@nl
P2093
P2860
P1476
Prognostic significance of CD147 in patients with glioblastoma.
@en
P2093
Fuqiang Feng
Guodong Gao
Jipei Zhao
Liang Wang
Peigang Ji
Shumei Wang
P2860
P2888
P356
10.1007/S11060-013-1207-2
P577
2013-08-08T00:00:00Z
P6179
1007608793